Skip to main content
Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
8.34
-0.20 (-2.34%)
Oct 22, 2024, 4:00 PM EDT - Market closed

Zevra Therapeutics Revenue

Zevra Therapeutics had revenue of $4.45M in the quarter ending June 30, 2024, a decrease of -47.47%. This brings the company's revenue in the last twelve months to $23.69M, up 43.21% year-over-year. In the year 2023, Zevra Therapeutics had annual revenue of $27.46M with 170.26% growth.

Revenue (ttm)
$23.69M
Revenue Growth
+43.21%
P/S Ratio
13.83
Revenue / Employee
$343,319
Employees
69
Market Cap
438.83M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202327.46M17.30M170.26%
Dec 31, 202210.16M-18.49M-64.53%
Dec 31, 202128.65M15.36M115.61%
Dec 31, 202013.29M449.00K3.50%
Dec 31, 201912.84M--
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Paragon 28 235.44M
Xeris Biopharma Holdings 181.41M
National Research 146.28M
GRAIL 109.74M
Theravance Biopharma 62.02M
Alector 55.28M
C4 Therapeutics 29.38M
4D Molecular Therapeutics 20.22M
Revenue Rankings

ZVRA News

More News